Ads
-
Related paper
- FORMULATION AND EVALUATION OF LIQUISOLID COMPACTS OF DABIGATRAN ETEXILATE MESYLATE
- FORMULATION AND EVALUATION OF EFAVIRENZ COMPACTS BY LIQUISOLID TECHNIQUE FOR SOLUBILITY ENHANCEMENT
- A RAPID STABILITY INDICATING RP-HPLC ASSAY METHOD DEVELOPMENT AND VALIDATION FOR THE QUANTITATIVE ESTIMATION OF DABIGATRAN ETEXILATE MESYLATE IN CAPSULES
- Expanding horizons of anticoagulant therapy: Dabigatran etexilate a novel oral anticoagulant
- Formulation and Evaluation of Curcumin Liquisolid Tablets
- Formulation and Evaluation of Nimodipine Tablet by Liquisolid Technique
- Formulation and Evaluation of Liquisolid Compact of Etoricoxib for Solubility Enhancement
- Formulation Development of Oral Liquisolid System of Poorly Water Soluble Drug, Piroxicam, Using Mixed Solvency Concept and their Evaluations
- FORMULATION, CHARACTERIZATION AND IN-VITRO EVALUATION OF NANOSUSPENSION FORMULATION OF CLOPIDOGREL USING SOLVENT-ANTISOLVENT TECHNIQUE
- STANDARDIZATION, FORMULATION AND EVALUATION OF COX-2 INHIBITOR FORMULATION IN SEMISOLID DOSAGE FORM SUITABLE FOR USE IN MUSCULOSKELETAL DISORDERS
